Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$70.0K
7.53K shares
What this filing means
METZGER MICHAEL A plans to sell 7.53K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $70.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/16/2025ACC: 0001959173-25-004605
Officer· President and COO
Since Feb 2019
7.53K
Shares to sell
$70.0K
Approx. market value
7.53K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/30/2025
7.53KTotal acquired7.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/30/2025 | Restricted Stock Vesting Compensation | 7.53K | — |
| Total | 7.53K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.53K
Market value
$70.0K
7/16/2025
Total
Units
7.53K
Value
$70.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/16/2025 | 7.53K | $70.0K | NASDAQ | Planned |
| Total | 7.53K | $70.0K | ||